| Line Item | 2023-03-31 | Y/Y |
|---|---|---|
| Revenue | $3.08B | +1.2% |
| Cost of Revenue | $2.05B | +5.9% |
| Gross Profit | $1.03B | -7.1% |
| R&D Expense | $44.2M | +53.8% |
| SG&A Expense | $504.5M | +16.2% |
| Operating Income | $107.9M | -83.3% |
| Income Tax | $60.4M | -59.1% |
| Net Income | -$9.7M | -102.1% |
| EPS (Basic) | -$0.17 | -102.1% |
| EPS (Diluted) | -$0.17 | -102.1% |
| Line Item | 2023-03-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $86.2M | +281.7% |
| Accounts Receivable | $339.4M | -4.9% |
| Inventory | $709.9M | +10.4% |
| Current Assets | $1.20B | +7.7% |
| Total Assets | $2.80B | +16.8% |
| Current Liabilities | $453.9M | +15.2% |
| Long-term Debt | $1.05B | +57.6% |
| Line Item | 2023-03-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $486.2M | +52.7% |
| Capital Expenditures | $38.8M | -9.3% |
| Investing Cash Flow | -$789.7M | -34.3% |
| Financing Cash Flow | $367.2M | +649.9% |
| Free Cash Flow | $447.4M | +62.4% |
| Total Liabilities |
| $1.67B |
| +31.1% |
| Stockholders' Equity | $1.13B | +0.7% |